Cepharanthine Completed Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) / Asymptomatic COVID-19 Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05398705 | Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19 |